The Optejet® ophthalmic drug device is designed to precisely administer medication to the eye, potentially treating patients' conditions through gentler, more efficient dosing.

FDA 510 (K) clearance was based on a pivotal clinical trial evaluating the safety and effectiveness of this novel eye-tracking-based amblyopia therapy vs eye patching, the gold standard.

Entrepreneur-eye surgeon continues his family's legacy in the field of ophthalmology, as Eyenovia's new Chairman

With the new surgeon, the practice becomes more poised to meet the growing demand for non-invasive cosmetic care in the region

While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an easier, more accurate and appropriate dose directly where it is needed in the eye.

This short film shows how TCM orthopedics restore bone injuries with just their fingers

The new EVO ICL eliminates the need for most glasses and contact lenses for qualifying patients.

Retina Technologies is developing a modular digital vision screening platform to provide fast and affordable vision testing for early detection of eye disorders.

Leading Ophthalmology Practice, Coastal Vision Medical Group Among First to Offer EVO Visian ICL in Southern California to Provide Visual Freedom from Glasses and Contact Lenses

The Power List includes the top 100 most influential people in the world of ophthalmology.

The newly approved connected device will facilitate patient access and communication between patients and eye care providers, collect data, and provide a platform between home and office to optimize treatment for dry eye

Using Vision Correction as a Mindset, Commitment, and Desire to Fight for a Patient's Best Vision Potential

Digital treatment device proven non-inferior to gold-standard eye patch treatment in multi-center randomized controlled study

People are embracing the most advanced SMILE laser vision correction to regain their visual freedom with minimal postoperative dryness

Offers one of the largest online selections of exclusive frames at a single retailer

Novel sustained-release technology has potential to eliminate the need for eye drops after cataract surgery.

Optical center brings patient-centric care and eyewear to Faribault community

Otus is a home eye care smart device one can use to manage eyesight with ease and convenience.

With its first fellowship trainee for oculoplastic surgery, Wilmington Eye seeks to invest in future talent in the field of ophthalmology.

Patients in Wilmington and the surrounding area now have expanded access to preventative and routine eye care on the weekends.

Americans are choosing to get ReLEx SMILE, an advanced form of LASIK, to achieve clear vision and eliminate their foggy glasses.

2021 is one of the most successful years in DAC's history

Company's support helps people in need afford vision care

Practice is participating in Kids With a Vision program

Organizations partner on back-to-school screening campaign

Available for Optomed Handheld Fundus Cameras

The Optomed Polaris and Optomed Halo are now available in the U.S.

Company's contributions help foundation expand reach

Program will enable practices to support the cause of vision in their communities

The in-vitro studies performed in Glauconix's co-culture 3D conventional human outflow model confirm efficacy

Time To Be Bold is a national public service awareness campaign helping the three million Americans 55 or older who are struggling with low vision regain their independence.

An objective, accurate and repeatable way to measure eye alignment

3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema.

Organizations work together to support charitable eye doctors

NovaSight has announced that it is running a large, pivotal multi-center randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for Amblyopia (Lazy Eye).

Appointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market

Company donates to support Essilor Vision Foundation

Today, Tangible Science announces that their long-awaited conditioning solution, Tangible Boost, is now available for purchase for both patients and Eye Care Practitioners.